Extrahepatic Cholangiocarcinoma

general

A cholangiocarcinoma that arises from the extrahepatic bile ducts. It includes hilar (perihilar) cholangiocarcinoma and distal cholangiocarcinoma (distal bile duct adenocarcinoma).

Centers

Active Trials

$5.8B

Cancer Funding

Specific Cancer Types(2)

Name	Centers	Active Trials
Hilar Cholangiocarcinoma	27	—
Recurrent Extrahepatic Cholangiocarcinoma	—	—

Top Centers for Extrahepatic Cholangiocarcinoma(30)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	56.2
2	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	1	—	56.2
3	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	56.2
4	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	1	—	56.2
5	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	1	—	56.2
6	Stony Brook Cancer CenterStony Brook, NY Active Research Program	Active Research Program	1	—	56.2
7	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	1	—	56.2
8	Northwell Health Cancer InstituteNew York, NY Active Research Program	Active Research Program	1	—	56.2
9	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive		—	$754M	—
10	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive		—	$534M	—
11	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive		—	$517M	—
12	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive		—	$507M	—
13	Duke Cancer InstituteDurham, NC NCI Comprehensive		—	$454M	—
14	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive		—	$370M	—
15	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive		—	$347M	—
16	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive		—	$333M	—
17	University of Colorado Cancer CenterAurora, CO NCI Comprehensive		—	$319M	—
18	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive		—	$276M	—
19	UF Health Cancer InstituteGainesville, FL NCI Clinical		—	$257M	—
20	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive		—	$227M	—
21	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical		—	$194M	—
22	University of Illinois Cancer CenterChicago, IL		—	$122M	—
23	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	$116M	—
24	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive		—	$110M	—
25	Boston University Cancer CenterBoston, MA		—	$98M	—
26	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive		—	$94M	—
27	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX		—	$83M	—
28	Cancer Center at IllinoisUrbana, IL		—	$81M	—
29	Loma Linda University Cancer CenterLoma Linda, CA		—	$10M	—
30	Tampa General Hospital Cancer InstituteTampa, FL		—	—	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →